Related Experiment Video
Updated: May 21, 2026

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
Published on: September 22, 2023
Independent and Opposing Effects of Radiological Disease Burden and Type 2 Inflammation on Nasal Nitric Oxide in
Siyi Tang1,2,3,4,5, Xing Lin1,2,3,4,5, Yunshan Fu1,2,3,4,5
1Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Abstract:
BackgroundIn chronic rhinosinusitis (CRS), nasal nitric oxide (nNO) levels are concurrently influenced by radiological disease burden and type 2 (T2) inflammation, yet their independent and interactive effects remain unquantified.ObjectiveTo quantify the independent and opposing effects of radiological disease burden (Lund-Mackay [LMK] score) and type 2 (T2) inflammation on nNO in patients with CRS.MethodsA total of 169 CRS patients undergoing sinus surgery were enrolled. Radiologic burden was quantified using the LMK score, assessed both continuously and by tertiles (low, mid, high). T2 inflammation was stratified based on fractional exhaled nitric oxide (FeNO) and peripheral blood eosinophils into T2-Low/Low, T2-Mid, and T2-High/High groups. nNO was measured using a standardized protocol. Multivariable linear regression was performed with log-transformed nNO as the outcome, adjusting for clinical and inflammatory covariates. Percentage change (%Δ) was back-calculated from the regression coefficients.ResultsEach one-point increase in LMK score was associated with an 8.8% decrease in nNO (95% confidence interval [CI], -10.9% to -6.7%; p < .001). The T2-High/High phenotype was independently associated with an 86.9% increase in nNO (95% CI, +28.7% to +171.4%; p = .001). LMK score remained inversely correlated with nNO across all T2 strata (interaction p = .237). In the LMK-High group, nNO levels were significantly reduced across all T2 categories (13.2%-19.1% decrease; all p ≤ .031).ConclusionIn CRS, radiological disease burden and T2 inflammation exert opposing yet independent effects on nNO. Structural obstruction predominantly lowers nNO, whereas high T2 inflammation may partially offset this reduction. These findings support the role of nNO as a composite biomarker integrating both anatomical patency and inflammatory activity, which can be utilized for CRS phenotyping and treatment monitoring.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Asthma I: Introduction
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inflammatory Bowel Disease III: Crohn's Disease